APA (7th ed.) Citation

Zhang, L., & Jordan, K. (2018). A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC). Annals of oncology, 29(2), . https://doi.org/10.1093/annonc/mdx698

Chicago Style (17th ed.) Citation

Zhang, Li, and Karin Jordan. "A Randomized Phase III Study Evaluating the Efficacy of Single-dose NEPA, a Fixed Antiemetic Combination of Netupitant and Palonosetron, Versus an Aprepitant Regimen for Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in Patients Receiving Highly Emetogenic Chemotherapy (HEC)." Annals of Oncology 29, no. 2 (2018). https://doi.org/10.1093/annonc/mdx698.

MLA (9th ed.) Citation

Zhang, Li, and Karin Jordan. "A Randomized Phase III Study Evaluating the Efficacy of Single-dose NEPA, a Fixed Antiemetic Combination of Netupitant and Palonosetron, Versus an Aprepitant Regimen for Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in Patients Receiving Highly Emetogenic Chemotherapy (HEC)." Annals of Oncology, vol. 29, no. 2, 2018, https://doi.org/10.1093/annonc/mdx698.